Vanda Pharmaceuticals | Der Umsatz





Der Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 278.6M 14M 2025-09
Agios Pharmaceuticals USD 12.9M 450K 2025-09
Akebia Therapeutics USD 57.34M 10.84M 2025-03
Alnylam Pharmaceuticals USD 1.25B 476.31M 2025-09
Anika Therapeutics USD 26.17M 12.58M 2025-03
Arrowhead Research USD 264.03M 7.56M 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Esperion Therapeutics USD 51.63M 22.2M 2024-09
Halozyme Therapeutics USD 354M 148M 2025-09
Heron Therapeutics USD 32.81M 3.21M 2024-09
Insmed USD 142M 34.6M 2025-09
J&J USD 24.6B 610M 2025-12
Lexicon Pharmaceuticals USD 1.65M 520K 2024-06
Ligand Pharmaceuticals USD 115.46M 67.83M 2025-09
Merck USD 16.4B 880M 2025-12
Minerva Neurosciences USD 0 0 2024-09
Moderna USD 1.02B 878M 2025-09
Novartis USD 14.36B 478M 2025-09
Pfizer USD 17.58B 880M 2025-12
PTC Therapeutics USD 211M 32.1M 2025-09
Puma Biotechnology USD 80.54M 33.46M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.3B 1.13B 2025-12
Takeda JPY 1.19T 80B 2025-12
Teva Pharmaceutical Industries USD 14.63B 10M 2025-12
Ultragenyx Pharmaceutical USD 160M 6.5M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Veracyte USD 131.9M 1.74M 2025-09


Vanda Pharmaceuticals Der Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.